What is it about?

To investigate whether neurofilament light polypeptide (NfL) level in cerebrospinal fluid (CSF), currently a prognostic biomarker of neurodegeneration in patients with multiple sclerosis (MS), may be a potential biomarker of cognitive dysfunction in MS.

Featured Image

Why is it important?

This study provides preliminary evidence for an association between CSF NfL levels and cognition in progressive forms of MS, which requires validation in larger samples.An inversely proportional association between CSF NfL levels and BICAMS z-scores was found in progressive forms of MS (rp = -0.944).

Perspectives

Many factors contribute to cognitive decline in MS, The detailed analysis of the CSF may through some light in the neurochemical and cellular interactions which occur in the perpetual mechanisms which result to cognitive impairment

Professor Stavros J Baloyannis or Balogiannis or Balojannis or Baloyiannis or Mpalogiannis
Aristotle University of Thessaloniki

Read the Original

This page is a summary of: Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis?, Journal of International Medical Research, April 2019, SAGE Publications,
DOI: 10.1177/0300060519840550.
You can read the full text:

Read

Contributors

The following have contributed to this page